Clinical and Molecular Characteristics of X-linked Agammaglobulinemia Patients 55 Years or Older

Further Publications Rheumatology

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study

Arthritis Res Ther

Baraliakos X, van der Heijde D, Sieper J, Inman RD, Kameda H, Maksymowych WP, Lagunes-Galindo I, Bu X, Wung P, Kato K, Shmagel A, Deodhar A

doi: 10.1186/s13075-024-03412-8

Autoimmune Disease

Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes

Clin Immunol

Ayyad M, Alya WA, Barabrah AM, Darawish SM, AlHabil Y, MohammedAli M, Nabilsi MZ, Asad D, Ayasa LA, Matassa D

doi: 10.1016/j.clim.2025.110512

Psoriatic Arthritis

Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial

RMD Open

McInnes IB, Sewerin P, Sharaf M, Efficace M, Lavie F, Zimmermann M, Coates LC

doi: 10.1136/rmdopen-2024-004494

Alopecia Areata

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme

J Eur Acad Dermatol Venereol

King B, Mirmirani P, Lo Sicco K, Ramot Y, Sinclair R, Asfour L, Ezzedine K, Paul C, Ohyama M, Edwards RA, Bonfanti G, Kerkmann U, Wajsbrot D, Ishowo-Adejumo R, Zwillich SH, Lejeune A

doi: 10.1111/jdv.20547

Osteoarthritis

Comparison of Results of Total Hip Arthroplasty in Patients Under 50 Years Who Had Osteonecrosis of the Femoral Head or Osteoarthritis: A Propensity-Matched Cohort Study From the Geneva Arthroplasty Registry With a Mean 12-Year Follow-Up

J Arthroplasty

Favre T, Bouché PA, Zingg M, Gauthier M, Lübbeke A, Hannouche D

doi: 10.1016/j.arth.2025.05.107

Further Publications Immunology

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

Arthritis Care Res (Hoboken)

Ahmadzadeh Y, Magder LS, de Andrade DCO, Paredes-Ruiz D, Tektonidou MG, Pengo V, Sciascia S, Andreoli L, Signorelli F, Fortin PR, Efthymiou M, Belmont HM, Barilaro G, Clarke AE, Atsumi T, López-Pedrera C, Knight JS, Branch DW, Willis R, Kello N, Zhang Z, Rodriguez Almaraz E, Artim-Esen B, Pardos-Gea J, Pons-Estel G, Pazzola G, Shi H, Duarte-García A, Thaler J, Barber MRW, Skeith L, Radin M, Meroni PL, Roubey R, Bertolaccini ML, Cohen H, Petri M, Erkan D

doi: 10.1002/acr.25503

Psoriatic Arthritis

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

J Rheumatol

Gladman DD, Mease PJ, Gossec L, Husni ME, Gottlieb AB, Ink B, Bajracharya R, Coarse J, Lyris N, Lambert J, Tillett W

doi: 10.3899/jrheum.2024-0923

Psoriatic Arthritis

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Ther Adv Musculoskelet Dis

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA

doi: 10.1177/1759720X241288071

Further Publications Dermatology

Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma

JAMA Dermatol

Gram SB, Brusgaard K, Lei U, Sommerlund M, Vinding GR, Sleire SOK, Christensen AH, Fast SP, Bach R, Bygum A, Ousager LB

doi: 10.1001/jamadermatol.2024.4824

Related content

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study

Autoimmune hemolytic anemia in COVID-19 patients: A systematic review of 105 cases on clinical characteristics and outcomes

Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial

Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme

Comparison of Results of Total Hip Arthroplasty in Patients Under 50 Years Who Had Osteonecrosis of the Femoral Head or Osteoarthritis: A Propensity-Matched Cohort Study From the Geneva Arthroplasty Registry With a Mean 12-Year Follow-Up

Predictors of Mortality in Antiphospholipid Antibody Positive Patients: Prospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository ("Registry")

Bimekizumab Improves Patient-Reported Outcomes and Work Productivity in Patients with Psoriatic Arthritis: 1-Year Results from Two Phase 3 Studies

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Clinical and Genetic Findings in Patients With Palmoplantar Keratoderma